KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Vertex Pharmaceuticals (VRTX) Return on Assets (2016 - 2025)

Vertex Pharmaceuticals (VRTX) has 15 years of Return on Assets data on record, last reported at 0.16% in Q4 2025.

  • For Q4 2025, Return on Assets changed N/A year-over-year to 0.16%; the TTM value through Dec 2025 reached 0.16%, changed N/A, while the annual FY2025 figure was 0.16%, 19.0% up from the prior year.
  • Return on Assets reached 0.16% in Q4 2025 per VRTX's latest filing, up from 0.15% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.23% in Q1 2021 and bottomed at 0.04% in Q1 2025.
  • Average Return on Assets over 5 years is 0.16%, with a median of 0.17% recorded in 2024.
  • Peak YoY movement for Return on Assets: rose 6bps in 2021, then fell -22bps in 2025.
  • A 5-year view of Return on Assets shows it stood at 0.18% in 2021, then grew by 6bps to 0.19% in 2022, then fell by -15bps to 0.16% in 2023, then rose by 6bps to 0.17% in 2024, then decreased by -9bps to 0.16% in 2025.
  • Per Business Quant database, its latest 3 readings for Return on Assets were 0.16% in Q4 2025, 0.15% in Q3 2025, and 0.16% in Q2 2025.